Objective: A major part of the cytokines secreted from the immune system are interleukins (IL) and their main role is to stimulate the immune system cells. Therefore the genotypic effects of IL-6 and IL-10 on the immune system in CLL were investigated in the study. Method: For this purpose 100 patients diagnosed with CLL and 70 healthy individuals with no cancer history were included in the study. Polymorphisms at IL10 and IL 6 promoter regions (1082 A\G and 819 C\T) and IL6 (174 G\C) polymorphisms were analyzed with RT-PCR. Genotype and allele frequencies were directly calculated. Result: In 100 CLL patients, 45 wild type AA, 40 AG and 15 mutant type GG genotypes were found for the IL 10 1082 A\G region. Genotypic distribution of IL10 819 C\T region was determined as CC, BT and TT genotypes in 37, 50 and 13 patients, respectively. In IL 6 174 G\C region, GG, GC and CC genotypes were determined in 62, 30 and 8 patients, respectively. There is no statistically significant difference between the CLL patients and control groups in terms of IL10 1082 A\G, 819 C\T and IL 6 174 G/C regions (p> 0.05). As a result of the allele frequency calculation of the IL 10 1082 region, the values obtained were A (0.65), G (0.35) for the patient group and (0.61) and G (0.31) for the control group. 819 region allele frequencies were C (0.57) and T (0.33) in the patient group and C (0.48) and T (0.32) in the control group. The IL6 174 region was calculated as G (0.82), C (0.28) in the patient group and G (0.63), C (0.23) in the control group. Given the number of patients within the limits of this study, IL 10 and IL 6 genotype frequencies do not seem to be statistically related to CLL patients. Conclusion: Mutant alleles of all interleukin SNPs were determined at a higher frequency in the patient group as compared to the control group. Therefore, a potential correlation between the SNPs of these interleukins and CLL can be determined in future studies with a higher number of samples.
Yildiz, S., Bayil Oguzkan, S., Ozaslan, M., Kizikli, A., Halil Kilic, I., & Yilmaz, M. (2024). Interleukin-6 And Interleukin-10 Polymorphisms In Chronic Lymphoid Leukemia Patients. Asian Pacific Journal of Cancer Prevention, 25(2), 461-464. doi: 10.31557/APJCP.2024.25.2.461
MLA
Sanem Yildiz; Sibel Bayil Oguzkan; Mehmet Ozaslan; Alperen Kizikli; Ibrahim Halil Kilic; Mehmet Yilmaz. "Interleukin-6 And Interleukin-10 Polymorphisms In Chronic Lymphoid Leukemia Patients". Asian Pacific Journal of Cancer Prevention, 25, 2, 2024, 461-464. doi: 10.31557/APJCP.2024.25.2.461
HARVARD
Yildiz, S., Bayil Oguzkan, S., Ozaslan, M., Kizikli, A., Halil Kilic, I., Yilmaz, M. (2024). 'Interleukin-6 And Interleukin-10 Polymorphisms In Chronic Lymphoid Leukemia Patients', Asian Pacific Journal of Cancer Prevention, 25(2), pp. 461-464. doi: 10.31557/APJCP.2024.25.2.461
VANCOUVER
Yildiz, S., Bayil Oguzkan, S., Ozaslan, M., Kizikli, A., Halil Kilic, I., Yilmaz, M. Interleukin-6 And Interleukin-10 Polymorphisms In Chronic Lymphoid Leukemia Patients. Asian Pacific Journal of Cancer Prevention, 2024; 25(2): 461-464. doi: 10.31557/APJCP.2024.25.2.461
)